Dr. Dragony Fu's lab at the University of Rochester focuses on understanding the critical roles of tRNA modification enzymes in human health. They investigate how alterations in these enzymes can lead to diseases by studying their impact on tRNA structure, function, and the regulation of cellular processes. The lab aims to build new models to study these mechanisms, with the ultimate goal of uncovering therapeutic strategies for diseases linked to tRNA modifications.

Professor Serge Fuchs leads a lab focused on enhancing the effectiveness of CAR T cell therapy for solid tumors in cancer treatment. His research investigates how the tumor microenvironment suppresses CAR T cells and aims to develop strategies to improve their viability and anti-tumor efficacy. The lab employs various molecular techniques to understand these mechanisms and explore new interventions that could make CAR T therapy more successful against challenging cancer types.

Dr. Elaine Fuchs' lab at Rockefeller University studies how skin stem cells contribute to tissue growth, maintenance, and healing. The research focuses on understanding how these cells communicate with their environment and respond to signals, which is crucial for maintaining healthy skin and informing regenerative medicine. By investigating the mechanisms of stem cell behavior and their role in diseases like cancer, the lab aims to develop new therapeutic strategies for skin-related disorders.

Dr. Hironori Funabiki's lab at Rockefeller University focuses on understanding how chromosomes are inherited and maintained during cell division, processes that are crucial for preventing diseases like cancer. The lab utilizes innovative techniques involving Xenopus egg extracts to study the structure and regulation of nucleosomes, which are essential for the integrity of our genetic material. Through their research, they aim to uncover the roles of specific proteins in maintaining chromosome stability and preventing immune responses that could lead to cell death.

Dr. Bing Ye's lab focuses on understanding the neurological features associated with Down syndrome, particularly the roles of GABAergic systems in conditions like cognitive deficits and epilepsy. The research investigates molecular regulators that may contribute to these comorbidities, using mouse models to explore the impact of specific genes, such as DSCAM. This work aims to identify therapeutic targets that could improve outcomes for individuals with Down syndrome and similar neurological disorders.

Dr. Thomas F Gajewski's lab focuses on improving cancer immunotherapy treatments by investigating why some patients do not respond to anti-PD-1 therapies. By studying the immune environment of tumors and the genetics involved, the lab aims to discover new ways to enhance the effectiveness of these therapies. The research combines insights from clinical samples and mouse models to explore various avenues for boosting anti-tumor immune responses.

Dr. Roman R. Ganta's lab focuses on understanding and combating tick-borne diseases caused by the bacteria Ehrlichia chaffeensis and Anaplasma phagocytophilum. By developing new methods to grow these bacteria without host cells and creating genetic mutations, the lab aims to explore how these pathogens evade immune responses and cause persistent infections. This research has significant implications for public health, especially for high-risk populations affected by these diseases.

Dr. Thomas Garcia's lab at Baylor College of Medicine is focused on understanding the genetic causes of male infertility, which is not well understood currently. The research involves using advanced sequencing techniques to identify new genes that influence male fertility. By studying both blood and sperm samples and validating findings in mouse models, the lab aims to shed light on the genetics of infertility and potentially identify targets for new male contraceptive solutions.

Dr. Michele A Battle's lab focuses on understanding how gastric parietal cells function in the stomach. These cells are crucial for secreting acid and assisting with digestion. The lab is particularly interested in a protein called GATA4, which helps regulate how these cells work. By studying the roles of GATA4 and its effects on gastric health, the research has the potential to inform treatments for conditions like ulcers and gastric cancer.

Dr. Christopher A. Gaulke's lab investigates how exposure to common herbicides during development may affect our gut microbiome and, consequently, our health, particularly in relation to obesity. The lab aims to understand the biological pathways through which these chemicals disrupt microbial communities in our intestines and contribute to weight gain. The research combines various experimental techniques to link changes in the microbiome with physiological outcomes related to obesity.

Christina Gavegnano's lab at Emory University researches how to reduce HIV infection specifically within the central nervous system (CNS), which is a major barrier to curing the virus. By studying the drug baricitinib, the lab aims to see if it can effectively decrease HIV levels in the brain and improve the health of individuals living with HIV. The lab combines clinical studies with animal models to explore innovative treatments that might one day lead to a cure for HIV, improving the lives of those affected by the virus.

Dr. Alice F. Tarantal's research focuses on improving safety in gene editing therapies by developing precise immunoassays that can evaluate immune responses to these treatments. Her work aims to validate sensitive tests that assess the interaction of the immune system with gene editing tools used in clinical trials. Ultimately, her lab strives to ensure that these innovative therapies are safe and effective for human use.

The research lab of Dr. James T. Kadonaga focuses on understanding how genes are regulated in humans, particularly the processes involving RNA polymerase II transcription. By exploring the core promoter regions and the proteins that interact with them, the lab aims to unravel the complexities of gene expression that can lead to diseases, including cancer. The research also investigates the biological roles of specific nucleosome-binding proteins to deepen our understanding of gene regulation.

Dr. Thomas Fazzio's lab focuses on understanding the genetic and epigenetic mechanisms that drive early mammalian development. They utilize cutting-edge techniques to identify and characterize genetic variants within regulatory elements that influence gene expression. The lab's work aims to clarify how these genetic changes affect cell fate decisions, ultimately contributing to our understanding of developmental disorders and improving regenerative medicine strategies.

Dr. Daniel Michael Jordan's lab focuses on improving our understanding of genetic diseases and predicting disease risks for individuals with specific genetic markers. By using advanced techniques in deep learning, the lab analyzes large datasets from electronic health records and various biological sources. This research aims to bridge the gap between genetic information and its actual impact on health, making genetic testing results more practical for clinicians and patients.

Dr. Noah Rosenberg's lab at Stanford University focuses on understanding how genetic variations contribute to complex human diseases using population genetics. The lab employs large-scale sequencing studies to discover and analyze rare genetic variants, particularly those that are recessive and linked to disease risk. Their work aims to enhance research methodologies and develop user-friendly software tools for other researchers in the field.

Dr. Andreas Hochwagen's lab at New York University studies how organisms safely break their DNA to create genetic diversity. They focus on understanding programmed DNA double-strand breaks and their roles in meiotic recombination and ribosomal DNA variations. By using genetics and molecular biology techniques, the lab aims to gain insights into genome stability and its implications for human diseases.

Dr. Andrew Gentles' lab studies the complex ecosystems of tumors to understand how they affect treatment responses, particularly in rare cancers like clear cell ovarian and renal cancers. The team uses advanced techniques like single-cell RNA sequencing and imaging to identify specific cell types and their roles in disease progression and treatment outcomes. This research aims to enhance prognostic methods and improve therapeutic strategies for patients.

Dr. Saghi Ghaffari's lab at the Icahn School of Medicine focuses on understanding how certain cellular organelles, like mitochondria and lysosomes, play critical roles in blood cell development and leukemia. They explore how these organelles influence the maturation of red blood cells and the behavior of leukemic stem cells. By uncovering these mechanisms, the lab aims to develop new therapeutic strategies for blood disorders and leukemia.

David D Ginty's lab focuses on understanding how our sense of touch works, including how our body and brain process different types of tactile stimuli like pressure and texture. They explore the biology of sensory neurons in the skin and how these neurons develop and function in both healthy and disease conditions. By using advanced techniques and mouse models, the lab aims to uncover the underlying mechanisms of touch sensation and train the next generation of neuroscientists.